Biotech

All Articles

James Wilson leaving behind Penn to introduce two new biotechs

.After much more than three decades, genetics treatment innovator James Wilson M.D., Ph.D., is actua...

3 biotechs try to defeat the summer season warm by dropping staff

.As biotechs seek to switch a fresh page in August, at least three business have lost personnel in t...

venBio raises $528M for fifth lifestyle scientific researches VC fund

.Professional financial backing company venBio has actually lifted another half a billion dollars to...

Otsuka pays out $800M for Jnana and its own clinical-stage PKU medicine

.Otsuka Drug has actually gotten Boston-based Jnana Rehabs for $800 thousand so the Japanese biotech...

FibroGen gives up 75% people staff as resource fails 2 additional trials

.FibroGen is actually substantially restructuring its company, giving up 75% of its own USA team as ...

Tracon winds down full weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has determined to unwind operations full weeks after an injectable invulnera...

Ideaya bags option on Biocytogen bispecific ADC in $400M offer

.Ideaya Biosciences is wagering $400 thousand in biobucks that a bispecific antibody-drug conjugate ...

Takeda takes $140M loss on stopped working epilepsy medicine, proclaims FDA manage

.Our experts already know that Takeda is wishing to discover a path to the FDA for epilepsy medicati...

VBI Vaccines apply for bankruptcy, seeks possession sale

.Immunology biotech VBI Vaccinations is actually diverting dangerously near the moment of truth, wit...

Celldex anti-cKIT antibody reduce colonies in another phase 2 research

.It is actually hard to muscle in on a room as very competitive as immunology, but Celldex Therapies...